chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Unable to move her arm / cannot move both arms; And is having pain / arm-ache; This case was reported by a pharmacist via call center representative and described the occurrence of injected limb mobility decreased in a 24-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 7SY34, expiry date 13th January 2023) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis, Men B NVS (Bexsero) (batch number ABXA04AA, expiry date 28th February 2022) for prophylaxis and meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 14th July 2021, the patient received the 1st dose of Boostrix (intramuscular), Boostrix Pre-Filled Syringe Device, the 1st dose of Bexsero (intramuscular) and Bexsero Pre-Filled Syringe Device. In July 2021, 6 days after receiving Boostrix, Boostrix Pre-Filled Syringe Device, Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced injected limb mobility decreased and pain in arm. The patient was treated with antiinflammatory/antirheumatic products (Anti-Inflammatory). On an unknown date, the outcome of the injected limb mobility decreased and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the injected limb mobility decreased and pain in arm to be related to Boostrix, Boostrix Pre-Filled Syringe Device, Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received the first dose of Boostrix and Bexsero on the same day. The patient experienced arm-ache, was having pain and was not able to move both arms. Pharmacist wanted to know if this was likely to happen after 6 days of receiving the vaccine because it was the first time that a patient came up with this symptoms after receiving these vaccines. Pharmacist stated that both vaccines were administered in the shoulder muscle of each arm.  These symptoms were still present and were not resolved. The patient had seen her physician and was prescribed anti-inflammatory medication.   The father thought that the vaccine was not administered correctly.  The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021156450:Same reporter. FU1 - deleted.
the pain level it was a 6 and now it's up to 9; Everything is sore; The arm was sore but that it's hard to tell as everything is sore; A spontaneous report was received from a consumer concerning, a 66 years old, male patient, who received MODERNA'S COVID-19 vaccine (mRNA-1273) and experienced the arm was sore but that it's hard to tell as everything is sore/pain in extremity and everything is sore/myalgia, and the pain level it was a 6 and now it's up to 9/condition aggravated.  The patient's medical history was provided as rare autoimmune disease and extreme pain. Concomitant medications reported were prednisone, naproxen, paracetamol, oxycodone for drug use for unknown indication.  On 09 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number:004M20A/004M204) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On an unknown date, the patient experienced the arm was sore but that it's hard to tell as everything is sore, the pain level it was a 6 and now it's up to 9. The patient stopped taking the medication in order to receive the vaccine to avoid the diminishing of the efficacy and wanted to know when can start taking the prednisone again. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of events, the arm was sore but that it's hard to tell as everything is sore/pain in extremity and everything is sore/myalgia, and the pain level it was a 6 and now it's up to 9, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event (Vaccination site pain and myalgia) a causal relationship cannot be excluded. Very limited information regarding the event (condition aggravated) has been provided at this time. Noting underlying autoimmune disease may remain as risk factor. Further information has been requested.
Glucose high; Urea Nitrogen high; Creatinine high; EGFR low; Sodium low; Red Blood Cell Count low; Hemoglobin low; Hematocrit low; This is a spontaneous report received from a contactable reporter(s) (Physician), Program ID:.  An 88-year-old male patient received BNT162b2 (BNT162B2), on 04Mar2021 as dose 2, 0.3 ml single (Batch/Lot number: unknown) at the age of 88 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (COVID-19. mRNA. LNP-S. PF. 30 mcg/0.3 mL dose (Pfizer- BioNTech)), administration date: 08Feb2021, when the patient was 88-year-old, for COVID-19 Immunization. The following information was reported: BLOOD GLUCOSE INCREASED (non-serious), outcome "unknown", described as "Glucose high"; BLOOD UREA INCREASED (non-serious), outcome "unknown", described as "Urea Nitrogen high"; BLOOD CREATININE INCREASED (non-serious), outcome "unknown", described as "Creatinine high"; GLOMERULAR FILTRATION RATE DECREASED (non-serious), outcome "unknown", described as "EGFR low"; BLOOD SODIUM DECREASED (non-serious), outcome "unknown", described as "Sodium low"; RED BLOOD CELL COUNT DECREASED (non-serious), outcome "unknown", described as "Red Blood Cell Count low"; HAEMOGLOBIN DECREASED (non-serious), outcome "unknown", described as "Hemoglobin low"; HAEMATOCRIT DECREASED (non-serious), outcome "unknown", described as "Hematocrit low". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reporter Occupation/Specialty: MD. HPI:  f/u CKD 4/5, recovering from COVID. Fasting reference interval, For someone without known diabetes, a glucose value >125 mg/dL indicates that they may have diabetes and this should be confirmed with a follow-up test. The eGER was based on the CKD-EPI 2021 equation. To calculate the new eGFR from a previous Creatinine or Cystatin C result.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Left arm in pain for past 11 days. Arm is numb/almost paralyzed.
WRONG VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with mrna 1273 for prophylactic vaccination. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 204A21A, and batch number: 204A21A expiry: UNKNOWN) dose was not reported, administered on 01-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-JUN-2021, the subject experienced wrong vaccine administered. The action taken with covid-19 vaccine  was not applicable. The outcome of wrong vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20210604872.
FLUMIST given 10/16/14 about 2 pm, patient awoke with severe neck pain 10/17/14 seen in ER->torticollis dx.
Myalgia Left arm pain, nasal congestion, runny nose Narrative: stayed home from work
1 day after PNEUMOVAX (R) arm, developed pain and swelling (R) arm with redness.
No adverse affects from my first dose.  Eleven hours after my second dose I began experiencing headache, chills, nausea, vomiting, body aches, joint pain and fatigue.  It?s now been 22 hours since my second dose and I  still experiencing these symptoms.
Patient was given the Moderna covid half dose booster (.25ml) and about an hour later she started to get severe jaw pain and a headache.  She was given a Toradol injection for pain ordered by Dr.  but there was no relief.  She started to have nausea and vomiting here in office so Dr.  decided it was best if she be transported to the hospital.  Patient was sent to hospital via ambulance.
pain in armpit of injected arm; Injection site pain; injection site pain, significant swelling (walnut sized lump), and redness; injection site pain, significant swelling (walnut sized lump), and redness; Fever; chills; significant lymph node enlargement; This is a spontaneous report from a non-contactable consumer (patient). A 42-Year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL3247) via an unspecified route of administration in left arm 16Feb2021 for COVID-19 immunisation at workplace clinic. The patient's medical history and concomitant medication were not reported. She did not receive other vaccine in four weeks. She had no Covid prior vaccination and not tested Covid post vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL3247) via unspecified route of administration in left arm 26Jan2021 for COVID-19 immunisation at workplace clinic. The patient experienced injection site pain, significant swelling (walnut sized lump), and redness, fever, chills and significant lymph node enlargement, pain in armpit of injected arm on 17Feb2021. She did not receive treatment for adverse events. The outcome events was recovering.  No follow-up attempts were possible. No further information was expected.
he was real sick for 2 weeks; flu symptoms for 2 weeks; Initial information regarding an unsolicited valid non-serious social media case received from consumer or non-healthcare professional on 30-Nov-2020.  This case involved male patient (age not reported) who had real sick (illness) with flu symptoms for 2 weeks (influenza), when he received INFLUENZA VACCINE.  The patient's medical history included allergic to egg.  The patient's past medical treatment, vaccination, concurrent condition, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in November 2020 (reported: for 2 weeks) it was reported that, the patient was had real sick (illness) with flu symptoms (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will be no information available on the batch number for this case.
This spontaneous report was received from a medical assistant and unspecified reporter refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, drug reactions or allergies were not reported. On 09-AUG-2018, the patient was vaccinated with improperly stored dose of Oka-Merck PROQUAD, lot # N034561, expiration date: 03-JUN-2019, (dose and route of administration were not provided) for prophylaxis (incorrect product storage). The vaccine was reconstituted with sterile diluent which was properly stored. The vaccine underwent a temperature excursion -14 to -10 degrees Celsius for 3 hours and 30 minutes. Digital data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA006154: US-009507513-1809USA004439: US-009507513-1809USA004440: US-009507513-1809USA004442: US-009507513-1809USA004443: US-009507513-1809USA004444: US-009507513-1809USA004445: US-009507513-1809USA004446: US-009507513-1809USA004447: US-009507513-1809USA004448: US-009507513-1809USA004449.
Headache, Fever, Chills, abdominal pain, fatigue Narrative:
a rash appeared at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 03-Apr-2021, the patient experienced VACCINATION SITE RASH. At the time of the report, VACCINATION SITE RASH outcome was unknown. Not Related.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On 3/15/01, had DT Pediatric, Hib, IPV and MMR. Within 1 hours, post vax, had full body hives. He was treated with Benadryl and Ora Pred. Symptoms resolved on 3/19/01.
Exacerbated CHF x 6 weeks with multiple changes in medications.  ON continuous O2.  12/2 Extremely dyspnic with anxiety.  Crackles right lung, diminished breath sounds.  Increased peripheral edema.
Pt complained of a tingling feeling in her throat. Reminded her of the feeling she had in her throat when she had a reaction to tree nuts. Pt.'s pulse ox 99% and HR 74 BP 134/84. No c/o tongue swelling or Shortness of breath. Pt given water and. monitored for 45 minutes. No change in patients condition or vital signs. Pt remained stable. Upon leaving clinic VS remain stable. BP 132/78 Pulse ox 99% and HR 79. Pt left clinic with her mother (who is a nurse).
pt spiked t103 approx 1030PM on 4AUG94 day of vax; temp inc to 104; temp remained until 430AM; small red rash noted throughout body; pt hospitalized 5AUG94 through 7AUG94;
No immediate side effects except for a slightly sore arm.  Extreme fatigue began 4 days from date of injection and lasted to day 16.  Dizziness and nausea began about 10 days from date of injection but were intermittent.  Nausea and dizziness finally resolved around day 16.  No lasting side effects to-date.
About a week after vaccination, Patient didn't feel good complaining of nausea and back pain. Covid swab obtained and was negative. Patient stayed home the 12-14 with back pain, fever, and fatigue. Felt a little better on the 16th but still feels under the weather.
Aches; Fever; Chills; Redness injection site swelling under arm; Redness injection site swelling under arm; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EL1284, Expiration Date was not reported), via an unspecified route of administration, administered in right arm on 12Jan2021 (at the age of 57-year-old) as 2ND DOSE, SINGLE for covid-19 immunisation administered in Hospital. The medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID), started 10yrs; tamoxifen, started 4 yrs; vitamin c [ascorbic acid]; zinc all from an unspecified date to ongoing.  Historical vaccine included BNT162B2 for covid-19 immunization. On 12Jan2021 23:00 after 2nd dose the patient experienced, fever, chills, aches and Redness injection site swelling under arm. Admission to hospital is not involved. Therapeutic measures were taken for the events with Anti-inflammatory + Benadryl and Naproxen Sodium for taking is Redness injection site swelling under arm, Chills, Fever, Aches, 25 mg twice daily from 31Dec2020 to an unspecified date. The outcome for the events was resolved.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Myalgia, Fever, injection site "soreness" Narrative:  Other Relevant History:
Patient came in for 1000 appointment with primary care physician for 12 month check up. Physician deemed Patient healthy to receive recommended 12 month vaccines. Patient and parents came to Immunizations Clinic at 1030. Patient's record was verified that Patient was up to date on previous recommended vaccinations. Patient did not have any history of adverse reactions to vaccines. Patient and parents were advised that Patient was recommended to get PREVNAR, MMR, Varicella, VAQTA, and Influenza vaccines. Parents declined Influenza vaccine but consented to rest of vaccines. Vaccines were administered without difficulty or complications. Parents were educated on after vaccination care and signs of anaphylaxis. Parents were advised to stay with Patient in hospital vicinity for at least 15 minutes and to report any concerns or abnormalities in Patient behavior of health. Parents understood and complied. Parents and Patient returned to Immunizations Clinic at 1100. Parents reported that Patient was extremely lethargic and appeared to be "not normal". Parents also indicated that Patient had slight outbreak of hives on forehead; was extremely warm to the touch, and that there was significant redness on lower aspect of Patient's left thigh. Parents did not indicate that Patient was in significant distress or that Patient had any difficulty breathing. Immunizations Clinic staff observed the Patient and confirmed that Patient had no difficulties breathing and was not in significant distress, did have the indicators of hives on Patient forehead, did present significant redness on lower aspect of Patient's left thigh, and was warm to the touch. Patient and parents were referred to Emergency Department for continued observation and treatment.
Started out 02/07/2021, as 2 flat red spots on my right groin, then has spread around my hips and down thighs, a few on my arms, neck, and upper abdomen, and lower back. The spots grew bigger each day and looks like skin is peeled off. Bright red. They are still spreading every day.
Headache, very thirsty. Drank more water and sat down and symptoms went away after a couple hours
approximately 30 minutes after shot, experienced hot flash and my uvula swelled up and throat turned red. Difficulty swallowing occurred, but nothing life threatening. Called nurse from clinic.
pt recv vax 17DEC98 & 12FEB99 pt devel signs & sx consistent w/pneumonia;CXR showed no active disease;pt sx worsened;pt hosp 14FEB99 dx lt lower lobe pneumonia, hypoxia & dehydration;no cult were performed & causative organism ID;
At the time of the vaccination, she felt a burning sensation down to her wrist, daily pain with radiation of pain down back and neck. Site never got red or swollen. She felt that the placement of the vaccine was placed too high on her shoulder area.
Arm where injection given is still very painful 3 1/2 weeks later. Painful to lift arm, to move arm when first waking up in morning.
Information and follow-up information has been received from a physician concerning an 8 week old white male with no pre-existing medical conditions or allergies who on 13-NOV-2007 at 11:30 was inadvertently vaccinated IM with the first "pediatric dose" of VAQTA (lot# 657840/0797U) in the right anterolateral thigh.  There was no illness at the time of vaccination.  On that same day, an order was given for inactivated PEDVAXHIB but the nurse grabbed the vial of VAQTA because the vial and box looked the same as the PEDVAXHIB.  The patient was not experiencing any known symptoms.  The patient did not seek any medical attention.  There was no product quality complaint.  Additional information has been requested.
2 days after receiving the vaccine I woke up with a strange sensation in my left arm I thought it was asleep from sleeping in a weird position, but as I make a fist I have a severe weakness unlike anything I have ever felt. It's like the tendons in my hand have no strength and a slight tingling on my arm from the point of injection. I am really scared as I have never felt this kind of weakness in my arm.  I have no strength and I don't know if this is going to get worse it's only 2 days after the shot, I hope this goes away I am really scared.
Immediate welts and irritation at the injection site, grew to rash 3.5in in diameter over the course of the next couple days, began vomiting hourly 9/13/12 at 2:00 PM that lasted until 10:00 PM, began having diarrhea 9/15/12 at 4:30 PM every 10-15 minutes that lasted until 8:30 PM.
Employee stated she felt nauseous waiting for post vaccination reaction. Employee than went into restroom and vomited. At 14:20 Medical supervisor was call to help employee, she was monitored  30mins. Employee continue to vomit and stated she wanted to go home, EMS was call at 15:00. Employee taken to hospital. Employee left center at 15:25.
Guillain-Barre syndrome; Initial information received on 28-Nov-2020 regarding an unsolicited valid serious case from a consumer/non-healthcare professional via social media.  This case involves patient (unknown demographics) who had Guillain-Barre Syndrome-nearly died (Guillain-Barre syndrome) (GBS), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date (reported as in 1974), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious Guillain-Barre Syndrome (Guillain-Barre syndrome) (latency unknown) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant. It was reported all vaccines had side effects from near zero to severe.  No laboratory data reported.  It was not reported if the patient was receiving any corrective treatment.  At the time of reporting, the outcome was not reported for the event Guillain-Barre syndrome.  Information on the batch number to be requested.; Sender's Comments: Sanofi Company Comment dated 06-Dec-2020 : This poorly documented social media case concerns a patient of unknown demographics who had Guillain-Barre syndrome after vaccination with INFLUENZA VACCINE. Time to onset is unkwnon. Also, patient's medical condition at the time of vaccination, concomitant medications and lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
This spontaneous prospective pregnancy report as received from a registered nurse refers to a 31 year old pregnant female patient. The patient was 33 weeks and 6 days pregnant and did not have drug reactions/alleriges. Pertinent medical history was not provided. Concomitant medications included unspecified prenatal vitamin. On 04-MAY-2015, the patient was inadvertently vaccinated with a dose of GARDASIL (route intramuscular, lot # K006191, dose an expiration date were not reported) when she was indicated (unspecified) TDAP vaccination. There was no adverse experience reported. The patient did not receive any treatment and there was no lab diagnostics and studies were performed. The last menstrual period (LMP) was on an approximately 09-SEP-2014 (calculated on subtracting 33 weeks and 6 days of pregnancy from date 04-MAY-2015). Estimated due date (EDD) was on 16-JUN-2015. The patient's and pregnancy outcome were unknown. Additional information has been requested.